Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorCook, Judith A
Burke-Miller, Jane K
Cohen, Mardge H
Cook, Robert L
Wilson, Tracey E
Golub, Elizabeth T
Schwartz, Rebecca M
Howard, Andrea A
Plankey, Michael W
Grey, Dennis D
Publication Begin page1355
Publication End page1363
MetadataShow full item record
AbstractBackground: Longitudinal associations between patterns of crack cocaine use and progression of HIV-1 disease are poorly understood, especially among women. This study explores relationships between crack use and HIV-1 disease outcomes in a multicenter cohort of infected women. Methods: Subjects were 1686 HIV-seropositive women enrolled at six US research centers in the Women's Interagency HIV Study. Approximately 80% were non-white and 29% used crack during the study period. Cox survival and random regression analysis examined biannual observations made April 1996 through September 2004. Outcome measures included death due to AIDS-related causes, CD4 cell count, HIV-1 RNA level, and newly acquired AIDS-defining illnesses. Results: Persistent crack users were over three times as likely as non-users to die from AIDS-related causes, controlling for use of HAART self-reported at 95% or higher adherence, problem drinking, age, race, income, education, illness duration, study site, and baseline virologic and immunologic indicators. Persistent crack users and intermittent users in active and abstinent phases showed greater CD4 cell loss and higher HIV-1 RNA levels controlling for the same covariates. Persistent and intermittent crack users were more likely than non-users to develop new AIDS-defining illnesses controlling for identical confounds. These results persisted when controlling for heroin use, tobacco smoking, depressive symptoms, hepatitis C virus coinfection, and injection drug use. Conclusion: Use of crack cocaine independently predicts AIDS-related mortality, immunologic and virologic markers of HIV-1 disease progression, and development of AIDS-defining illnesses among women.
CitationCook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, Golub ET, Schwartz RM, Howard AA, Ponath C, Plankey MW, Levine AM, Grey DD. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS. 2008 Jul 11;22(11):1355-63. doi: 10.1097/QAD.0b013e32830507f2. Erratum in: AIDS. 2008 Sep 12;22(14):i. Levine, Andrea [corrected to Levine, Alexandra M]. PMID: 18580615; PMCID: PMC2645902.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
- Authors: Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A
- Issue date: 2009 Jan 1
- Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
- Authors: Martel-Laferrière V, Nitulescu R, Cox J, Cooper C, Tyndall M, Rouleau D, Walmsley S, Wong L, Klein MB, Canadian Co-infection Cohort Study Investigators
- Issue date: 2017 Jan 17
- Crack cocaine use increases the incidence of AIDS-defining events in French Guiana.
- Authors: Nacher M, Adenis A, Hanf M, Adriouch L, Vantilcke V, El Guedj M, Vaz T, Dufour J, Couppié P
- Issue date: 2009 Oct 23
- Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
- Authors: Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL
- Issue date: 2005 Mar 15
- Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.
- Authors: Sharpe TT, Lee LM, Nakashima AK, Elam-Evans LD, Fleming PL
- Issue date: 2004 Apr